drugset / Trial / NCT02572609
Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride
CrossoverOpen-labelTreatment
Summary
to evaluate the bioavailability of ambroxol hydrochloride soft pastilles (test formulation), manufactured by Bolder Arzneimittel GmbH \& Co. KG to Boehringer Ingelheim compared to ambroxol hydrochloride syrup (Mucosolvan® adult syrup), manufactured by Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda.
Timeline
- Start
- 2011-11
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ambroxol | Small molecule | — | — |
Indications
No indication recorded.